​

Crescent Biopharma Ownership | Who Owns Crescent Biopharma?

OverviewForecastFinancialsChart

Crescent Biopharma Ownership Summary

Crescent Biopharma is owned by 1244.12% institutional investors, 0.12% insiders.

CBIO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockCrescent Biopharma1244.12%0.12%-1144.24%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202529-10,751,740-1,244-29---
Dec 31, 20241-15---1---
Dec 31, 20231-96.88%66-100.00%-1.83%1-92.31%--100.00%
Sep 30, 20233210.34%2,152,048-5.20%-235.64%1362.50%7-12.50%
Jun 30, 202329-21.62%2,270,207-32.67%-112.98%8-55.56%860.00%

Recent Insider Transactions

DateNameRoleActivityValue
Aug 08, 2024Invus Public Equities, L.P.-Sell$50.01K
Aug 07, 2024Invus Public Equities, L.P.-Sell$11.20K
Aug 06, 2024Invus Public Equities, L.P.-Sell$10.19K
Aug 05, 2024Invus Public Equities, L.P.-Sell$31.00K
Aug 01, 2024Invus Public Equities, L.P.-Sell$13.74K

Insider Transactions Trends

DateBuySell
2025 Q3--
2025 Q2--

CBIO Ownership FAQ

Who Owns Crescent Biopharma?

Crescent Biopharma shareholders are primarily institutional investors at 1244.12%, followed by 0.12% insiders and -1144.24% retail investors. The average institutional ownership in Crescent Biopharma's industry, Biotech Stocks , is 306.59%, which Crescent Biopharma exceeds.

Does Blackrock own Crescent Biopharma?

BlackRock is not among the top 10 institutional shareholders of Crescent Biopharma.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools